Merck Sued by Patients Whose Jaws Were Damaged by Osteoporosis Drug

by Medindia Content Team on  December 2, 2007 at 4:16 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

Merck Sued by Patients Whose Jaws Were Damaged by Osteoporosis Drug
Barely has the drug giant Merck recovered from the Vioxx disaster, it is now confronted with suits demanding compensation from users of its osteoporosis drug Fosamax. They complain of severely damaged jaws.

Lawyers on Friday asked a federal judge in New York to order the company to provide a dental monitoring program for the drug's users.

They argued for the case to be certified as a class-action. Timothy M. O'Brien, a lawyer for plaintiffs, said hundreds of thousands of patients would benefit from a dental monitoring program that would include regular dental screenings, X-rays and lab tests, all aimed at preventing the need for dental surgery.

Paul Strain, a Merck attorney, called Fosamax a

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Pagets And Jaw Bone Diseases Drug Toxicity Fracture Rickets Osteoporosis Lifestyle And Osteoporosis Nervous Tic Kyphosis Signature Drug Toxicity Colle’s Fracture 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive

Loading...